Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts

Implication for the therapeutic effect of statin in atrial structural remodeling

Chia Ti Tsai, Ling Ping Lai, Kuan Ting Kuo, Juey Jen Hwang, Chia Shan Hsieh, Kuan Lih Hsu, Chuen Den Tseng, Yung Zu Tseng, Fu Tien Chiang, Jiunn Lee Lin

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

BACKGROUND - Recently, activation of the local renin-angiotensin system and mitogen-activated protein kinase pathways in atrial myocardium has been found to play an important role in atrial structural remodeling related to atrial fibrillation. Another important mediator of the angiotensin II (Ang II) effect is the Janus kinase/signal transducers and activators of transcription (STAT) pathway, which has never been characterized in the atrium. METHODS AND RESULTS - In cultured atrial myocytes and fibroblasts, Ang II induced tyrosine phosphorylation of STAT3 through a Rac1-dependent mechanism, which was inhibited by dominant-negative Rac1, losartan, and simvastatin. In atrial myocytes, activation of STAT3 by Rac1 was mediated by direct association of Rac1 with STAT3; however, in atrial fibroblasts, it was mediated by an indirect paracrine effect. Constitutively active STAT3 increased protein synthesis, and dominant-negative STAT3 abrogated Ang II-induced protein synthesis in atrial myocytes and fibroblasts. Rats infused long term with Ang II exhibited higher levels of activated Rac1, phospho-STAT3, collagen synthesis, and atrial fibrosis in the atria, all of which were attenuated by oral losartan and simvastatin. In human atrial tissues from patients with atrial fibrillation, Ang II and phospho-STAT3 levels were also elevated. CONCLUSIONS - The Ang II/Rac1/STAT3 pathway is an important signaling pathway in the atrial myocardium to mediate atrial structural remodeling, and losartan and statin may be able to reverse Ang II-induced atrial structural remodeling in atrial fibrillation.

Original languageEnglish
Pages (from-to)344-355
Number of pages12
JournalCirculation
Volume117
Issue number3
DOIs
Publication statusPublished - Jan 1 2008
Externally publishedYes

Fingerprint

Atrial Remodeling
Hydroxymethylglutaryl-CoA Reductase Inhibitors
STAT3 Transcription Factor
Therapeutic Uses
Angiotensin II
Muscle Cells
Fibroblasts
Losartan
Atrial Fibrillation
Simvastatin
Myocardium
Janus Kinases
Renin-Angiotensin System
Mitogen-Activated Protein Kinases
Transducers
Tyrosine
Fibrosis
Collagen
Phosphorylation

Keywords

  • Angiotensin II
  • Atrial fibrillation
  • Rac1 protein
  • Signal transduction
  • Small GTPases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts : Implication for the therapeutic effect of statin in atrial structural remodeling. / Tsai, Chia Ti; Lai, Ling Ping; Kuo, Kuan Ting; Hwang, Juey Jen; Hsieh, Chia Shan; Hsu, Kuan Lih; Tseng, Chuen Den; Tseng, Yung Zu; Chiang, Fu Tien; Lin, Jiunn Lee.

In: Circulation, Vol. 117, No. 3, 01.01.2008, p. 344-355.

Research output: Contribution to journalArticle

Tsai, Chia Ti ; Lai, Ling Ping ; Kuo, Kuan Ting ; Hwang, Juey Jen ; Hsieh, Chia Shan ; Hsu, Kuan Lih ; Tseng, Chuen Den ; Tseng, Yung Zu ; Chiang, Fu Tien ; Lin, Jiunn Lee. / Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts : Implication for the therapeutic effect of statin in atrial structural remodeling. In: Circulation. 2008 ; Vol. 117, No. 3. pp. 344-355.
@article{e812a54ed6f14c4f8c0b271cbb359cbf,
title = "Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: Implication for the therapeutic effect of statin in atrial structural remodeling",
abstract = "BACKGROUND - Recently, activation of the local renin-angiotensin system and mitogen-activated protein kinase pathways in atrial myocardium has been found to play an important role in atrial structural remodeling related to atrial fibrillation. Another important mediator of the angiotensin II (Ang II) effect is the Janus kinase/signal transducers and activators of transcription (STAT) pathway, which has never been characterized in the atrium. METHODS AND RESULTS - In cultured atrial myocytes and fibroblasts, Ang II induced tyrosine phosphorylation of STAT3 through a Rac1-dependent mechanism, which was inhibited by dominant-negative Rac1, losartan, and simvastatin. In atrial myocytes, activation of STAT3 by Rac1 was mediated by direct association of Rac1 with STAT3; however, in atrial fibroblasts, it was mediated by an indirect paracrine effect. Constitutively active STAT3 increased protein synthesis, and dominant-negative STAT3 abrogated Ang II-induced protein synthesis in atrial myocytes and fibroblasts. Rats infused long term with Ang II exhibited higher levels of activated Rac1, phospho-STAT3, collagen synthesis, and atrial fibrosis in the atria, all of which were attenuated by oral losartan and simvastatin. In human atrial tissues from patients with atrial fibrillation, Ang II and phospho-STAT3 levels were also elevated. CONCLUSIONS - The Ang II/Rac1/STAT3 pathway is an important signaling pathway in the atrial myocardium to mediate atrial structural remodeling, and losartan and statin may be able to reverse Ang II-induced atrial structural remodeling in atrial fibrillation.",
keywords = "Angiotensin II, Atrial fibrillation, Rac1 protein, Signal transduction, Small GTPases, Angiotensin II, Atrial fibrillation, Rac1 protein, Signal transduction, Small GTPases",
author = "Tsai, {Chia Ti} and Lai, {Ling Ping} and Kuo, {Kuan Ting} and Hwang, {Juey Jen} and Hsieh, {Chia Shan} and Hsu, {Kuan Lih} and Tseng, {Chuen Den} and Tseng, {Yung Zu} and Chiang, {Fu Tien} and Lin, {Jiunn Lee}",
year = "2008",
month = "1",
day = "1",
doi = "10.1161/CIRCULATIONAHA.107.695346",
language = "English",
volume = "117",
pages = "344--355",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts

T2 - Implication for the therapeutic effect of statin in atrial structural remodeling

AU - Tsai, Chia Ti

AU - Lai, Ling Ping

AU - Kuo, Kuan Ting

AU - Hwang, Juey Jen

AU - Hsieh, Chia Shan

AU - Hsu, Kuan Lih

AU - Tseng, Chuen Den

AU - Tseng, Yung Zu

AU - Chiang, Fu Tien

AU - Lin, Jiunn Lee

PY - 2008/1/1

Y1 - 2008/1/1

N2 - BACKGROUND - Recently, activation of the local renin-angiotensin system and mitogen-activated protein kinase pathways in atrial myocardium has been found to play an important role in atrial structural remodeling related to atrial fibrillation. Another important mediator of the angiotensin II (Ang II) effect is the Janus kinase/signal transducers and activators of transcription (STAT) pathway, which has never been characterized in the atrium. METHODS AND RESULTS - In cultured atrial myocytes and fibroblasts, Ang II induced tyrosine phosphorylation of STAT3 through a Rac1-dependent mechanism, which was inhibited by dominant-negative Rac1, losartan, and simvastatin. In atrial myocytes, activation of STAT3 by Rac1 was mediated by direct association of Rac1 with STAT3; however, in atrial fibroblasts, it was mediated by an indirect paracrine effect. Constitutively active STAT3 increased protein synthesis, and dominant-negative STAT3 abrogated Ang II-induced protein synthesis in atrial myocytes and fibroblasts. Rats infused long term with Ang II exhibited higher levels of activated Rac1, phospho-STAT3, collagen synthesis, and atrial fibrosis in the atria, all of which were attenuated by oral losartan and simvastatin. In human atrial tissues from patients with atrial fibrillation, Ang II and phospho-STAT3 levels were also elevated. CONCLUSIONS - The Ang II/Rac1/STAT3 pathway is an important signaling pathway in the atrial myocardium to mediate atrial structural remodeling, and losartan and statin may be able to reverse Ang II-induced atrial structural remodeling in atrial fibrillation.

AB - BACKGROUND - Recently, activation of the local renin-angiotensin system and mitogen-activated protein kinase pathways in atrial myocardium has been found to play an important role in atrial structural remodeling related to atrial fibrillation. Another important mediator of the angiotensin II (Ang II) effect is the Janus kinase/signal transducers and activators of transcription (STAT) pathway, which has never been characterized in the atrium. METHODS AND RESULTS - In cultured atrial myocytes and fibroblasts, Ang II induced tyrosine phosphorylation of STAT3 through a Rac1-dependent mechanism, which was inhibited by dominant-negative Rac1, losartan, and simvastatin. In atrial myocytes, activation of STAT3 by Rac1 was mediated by direct association of Rac1 with STAT3; however, in atrial fibroblasts, it was mediated by an indirect paracrine effect. Constitutively active STAT3 increased protein synthesis, and dominant-negative STAT3 abrogated Ang II-induced protein synthesis in atrial myocytes and fibroblasts. Rats infused long term with Ang II exhibited higher levels of activated Rac1, phospho-STAT3, collagen synthesis, and atrial fibrosis in the atria, all of which were attenuated by oral losartan and simvastatin. In human atrial tissues from patients with atrial fibrillation, Ang II and phospho-STAT3 levels were also elevated. CONCLUSIONS - The Ang II/Rac1/STAT3 pathway is an important signaling pathway in the atrial myocardium to mediate atrial structural remodeling, and losartan and statin may be able to reverse Ang II-induced atrial structural remodeling in atrial fibrillation.

KW - Angiotensin II

KW - Atrial fibrillation

KW - Rac1 protein

KW - Signal transduction

KW - Small GTPases

KW - Angiotensin II

KW - Atrial fibrillation

KW - Rac1 protein

KW - Signal transduction

KW - Small GTPases

UR - http://www.scopus.com/inward/record.url?scp=38349138319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349138319&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.107.695346

DO - 10.1161/CIRCULATIONAHA.107.695346

M3 - Article

VL - 117

SP - 344

EP - 355

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3

ER -